
Tags and Tails
Our mission is to create safe and supportive transitional housing for homeless veterans and area dogs while assisting both in rehabilitation and permanent homes To create a safe and supportive transitional housing facility for homeless Veterans and area homeless dogs while assisting them both in rehabilitation and finding permanent homes.

ICO
820880931
X (Twitter)
31
Address
Detroit
From Social media
News about from their social media (Facebook and X).
Data about organisation
Military/Veterans' Organizations Category
Organisations with similar rank to Tags and Tails in category Military/Veterans' Organizations

3985. National Association of Black Veterans Inc
We work to provide a “Better Life” for active duty service members, veterans and their families.

NC Licensed General Contractor providing commercial construction services for the Triangle and surro.
Detroit
Organisations from Tags and Tails

Mezuzah aims to advance permanent Jewish population growth in Detroit.
Interesting nearby
Interesting organisations close by to residence of Tags and Tails
More Interesting nearbySimilar social media (31)
Organisations with similar social media impact to Tags and Tails

A nonprofit organization committed to developing the careers of underrepresented storytellers.

Helping girls, teens, and young women boldly embrace their identity and be the change.

We are Sunny at the University of Michigan.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

🌟 Exciting news from Armenia! ASB Georgia is looking for international talent to help plan a full-scale exercise for the Armenian Emergency Medical Team. Together, we're building a stronger, more collaborative response to cross-border challenges! 💪🤝 #StrongerTogether #PositiveNews
Facilitator of EMT full-scale exercise - Armenia
ReliefWeb
Like Comment
Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment